Table 3.
Publications by classification category and result.
| Category | Sub-Categories | Positive (n %) | Neutral (n %) | Negative (n %) | References |
|---|---|---|---|---|---|
| Type of drugs | Asthma | 1 (5) | 0 (0) | 0 (0) | [40] |
| Cancer | 1 (5) | 1 (5) | 0 (0) | [38,66] | |
| Cystic fibrosis | 1 (5) | 0 (0) | 0 (0) | [40] | |
| Depression | 1 (5) | 0 (0) | 0 (0) | [32] | |
| HIV | 1 (5) | 0 (0) | 0 (0) | [31] | |
| Rheumatoid arthritis | 1 (5) | 0 (0) | 0 (0) | [40] | |
| Type 2 diabetes | 1 (5) | 0 (0) | 0 (0) | [40] | |
| Unknown | 10 (53) | 1 (5) | 0 (0) | [33,34,35,36,37,39,41,67,68,69,70] | |
| Data source | Drug reviews | 4 (22) | 0 (0) | 0 (0) | [35,38,39,40] |
| Electronic Health Records (EHR) | 1 (6) | 0 (0) | 0 (0) | [69] | |
| Forums | 3 (17) | 0 (0) | 0 (0) | [32,68,70] | |
| Social media | 8 (44) | 2 (11) | 0 (0) | [31,33,34,36,37,39,40,41,66,67] | |
| Origin of users | Canada | 1 (5) | 0 (0) | 0 (0) | [31] |
| South Africa | 1 (5) | 0 (0) | 0 (0) | [31] | |
| United Kingdom | 1 (5) | 0 (0) | 0 (0) | [31] | |
| United States | 1 (5) | 0 (0) | 0 (0) | [31] | |
| Unknown | 13 (68) | 2 (11) | 0 (0) | [32,33,34,35,36,37,38,39,40,41,66,67,68,69,70] | |
| Horizon of data collection | 1 year | 1 (6) | 1 (6) | 0 (0) | [36,66] |
| 2 to 5 years | 1 (6) | 0 (0) | 0 (0) | [31] | |
| 6 to 10 years | 1 (6) | 0 (0) | 0 (0) | [32] | |
| Not applicable | 4 (25) | 0 (0) | 0 (0) | [40,41,68,69] | |
| Unknown | 7 (44) | 1 (6) | 0 (0) | [33,34,35,37,38,39,67,70] | |
| Outcome | Patient satisfaction with drugs | 1 (6) | 0 (0) | 0 (0) | [35] |
| Patient-reported medication outcomes | 1 (6) | 0 (0) | 0 (0) | [40] | |
| Reported ADRs | 10 (56) | 1 (6) | 0 (0) | [33,34,35,36,37,39,41,67,68,69,70] | |
| Reported ADRs for cancer | 0 (0) | 1 (6) | 0 (0) | [66] | |
| Reported ADRs for HIV treatment | 1 (6) | 0 (0) | 0 (0) | [31] | |
| Reported effectiveness of drugs | 1 (6) | 0 (0) | 0 (0) | [35] | |
| User sentiment on depression drugs | 1 (6) | 0 (0) | 0 (0) | [32] | |
| User sentiment on cancer drugs | 1 (6) | 0 (0) | 0 (0) | [38] | |
| Drugs studied | Less than 5 | 1 (6) | 0 (0) | 0 (0) | [31] |
| 5 to 9 | 3 (19) | 1 (6) | 0 (0) | [32,41,66,69] | |
| 10 to 14 | 2 (13) | 0 (0) | 0 (0) | [40,70] | |
| 15 to 19 | 0 (0) | 0 (0) | 0 (0) | - | |
| 20 or more | 5 (31) | 0 (0) | 0 (0) | [36,38,39,67,68] | |
| Unknown | 3 (19) | 1 (6) | 0 (0) | [33,34,35,37] | |
| Reliability | Low | 0 (0) | 0 (0) | 0 (0) | - |
| Medium | 14 (88) | 2 (13) | 0 (0) | [31,32,33,34,35,36,37,38,39,40,41,66,67,68,69,70] | |
| High | 0 (0) | 0 (0) | 0 (0) | - | |
| Validity | Low | 0 (0) | 0 (0) | 0 (0) | - |
| Medium | 14 (88) | 2 (13) | 0 (0) | [31,32,33,34,35,36,37,38,39,40,41,66,67,68,69,70] | |
| High | 0 (0) | 0 (0) | 0 (0) | - |